Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages

Go back to Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages
(NASDAQ: QTRX) Delayed: 3.84 --0 (-0%)
Previous Close $3.84    52 Week High
Open $3.84    52 Week Low
Day High $3.84    P/E N/A 
Day Low $3.84    EPS
Volume 57